Michael T. Piascik

University of Kentucky — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index3.0kcitations57works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(36), Neuropeptides and Animal Physiology(17), Adipose Tissue and Metabolism(9), Neuroscience and Neuropharmacology Research(8), Nitric Oxide and Endothelin Effects(8)

Publications57 total

Hypertension update, JNC8 and beyond
Current Opinion in Pharmacology·2017· 41 cited
Adrenergic Agonists
Elsevier eBooks·2017· 1 cited
Contributors
Elsevier eBooks·2017
Adrenergic Antagonists
Elsevier eBooks·2017
Introduction to Autonomic Nervous System Drugs
Elsevier eBooks·2017· 6 cited
Impact of lecturetools on student engagement and learning (1058.4)
The FASEB Journal·2014
A Pilot Study on the Use of Lecture Tools to Enhance the Teaching of Pharmacokinetics and Pharmacodynamics
Journal of Medical Education and Curricular Development·2014· 5 citedOpen Access
α1A-Adrenergic Receptors Regulate Cardiac Hypertrophy In Vivo Through Interleukin-6 Secretion
Molecular Pharmacology·2013· 14 citedOpen Access
The α1D-Adrenergic Receptor Induces Vascular Smooth Muscle Apoptosis via a p53-Dependent Mechanism
Molecular Pharmacology·2008· 18 cited
The Role of the Tumor Supressor‐p53 in Alpha1D‐Adrenergic Receptor (AR) Induce Apoptosis in Vascular Smooth Muscle Cells
The FASEB Journal·2008
The α<sub>1D</sub>-adrenergic receptor is expressed intracellularly and coupled to increases in intracellular calcium and reactive oxygen species in human aortic smooth muscle cells
Journal of Molecular Signaling·2008· 21 citedOpen Access
Regulation of the Cellular Localization and Trafficking of the Adrenergic Receptors
Humana Press eBooks·2006
Differential Cardiovascular Regulatory Activities of the α1B- and α1D-Adrenoceptor Subtypes
Journal of Pharmacology and Experimental Therapeutics·2003· 58 cited
Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the α1-Adrenoceptor Subtypes
Molecular Pharmacology·2002· 19 cited
Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the α<sub>1</sub>-Adrenoceptor Subtypes
Molecular Pharmacology·2002· 130 cited
α1B- and α1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts
Journal of Pharmacology and Experimental Therapeutics·2002· 24 cited
α1-Adrenergic Receptors: New Insights and Directions
Journal of Pharmacology and Experimental Therapeutics·2001· 167 cited
Hypotension, Autonomic Failure, and Cardiac Hypertrophy in Transgenic Mice Overexpressing the α1B-Adrenergic Receptor
Journal of Biological Chemistry·2001· 101 citedOpen Access
Regulation of the Cellular Localization and Signaling Properties of the α<sub>1B</sub>- and α<sub>1D</sub>-Adrenoceptors by Agonists and Inverse Agonists
Molecular Pharmacology·2000· 95 cited
Regulation of the Cellular Localization and Signaling Properties of the α1B- and α1D-Adrenoceptors by Agonists and Inverse Agonists
Molecular Pharmacology·2000· 11 cited
page 1 of 3Next →

Frequent Co-authors

Dianne M. Perez(15), Dan F. McCune(7), Stephanie E. Edelmann(7), Dan Chalothorn(4), Mary L. Garcı́a-Cazarı́n(4), David Waugh(4), Ginell R. Post(4), James D. Potter(4), Brent T. Butler(4), Michael Babich(4), Duane D. Miller(4), Dennis R. Feller(4), Robert M. Graham(3), Gozoh Tsujimoto(3), Michael J. Zuscik(3), Edward E. Soltis(3), Jennifer R. Olges(3), Bruce A. Waldrop(3), Mary F. Piascik(3), Scott R. Hamann(3)